AYTU BIOPHARMA, INC Costs and Expenses, Related Party
AYTU BIOPHARMA, INC (AYTU) reported Costs and Expenses, Related Party of $0 for the 12-month period ending 2020-06-30, per its 10-K filed 2020-10-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpensesRelatedParty · last filed 2020-10-06
- AYTU BIOPHARMA, INC costs and expenses, related party for the quarter ending 2020-06-30 was $0.00.
- AYTU BIOPHARMA, INC costs and expenses, related party for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC costs and expenses, related party for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC costs and expenses, related party for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC costs and expenses, related party for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- AYTU BIOPHARMA, INC costs and expenses, related party for fiscal 2019 was $351.84K.
- AYTU BIOPHARMA, INC costs and expenses, related party for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- AYTU BIOPHARMA, INC costs and expenses, related party for fiscal 2017 was $165.13K, a 46.33% decline from fiscal 2016.
| Period end | Costs and Expenses, Related Party 3 month | Costs and Expenses, Related Party 6 month | Costs and Expenses, Related Party 9 month | Costs and Expenses, Related Party 12 month |
|---|---|---|---|---|
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | $0.00 derived: sum of 2 quarters · filed 2020-10-06 | $0.00 derived: sum of 3 quarters · filed 2020-10-06 | $0.00 10-K · filed 2020-10-06 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-15 | $0.00 derived: sum of 2 quarters · filed 2020-05-15 | $0.00 10-Q · filed 2020-05-15 | $0.00 derived: sum of 4 quarters · filed 2020-10-06 |
| 2019-12-31 | $0.00 10-Q · filed 2020-02-14 | $0.00 10-Q · filed 2020-02-14 | $0.00 derived: sum of 3 quarters · filed 2020-10-06 | $6.80K derived: sum of 4 quarters · filed 2020-10-06 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2020-10-06 | $6.80K derived: sum of 3 quarters · filed 2020-10-06 | $98.13K derived: sum of 4 quarters · filed 2020-10-06 |
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | $6.80K derived: sum of 2 quarters · filed 2020-10-06 | $98.13K derived: sum of 3 quarters · filed 2020-10-06 | $351.84K 10-K · filed 2020-10-06 |
| 2019-03-31 | $6.80K 10-Q · filed 2020-05-15 | $98.13K derived: sum of 2 quarters · filed 2020-05-15 | $351.84K 10-Q · filed 2020-05-15 | $351.84K derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $91.34K 10-Q · filed 2020-02-14 | $345.05K 10-Q · filed 2020-02-14 | $345.05K derived: sum of 3 quarters · filed 2020-02-14 | $345.05K derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-09-30 | $253.71K 10-Q · filed 2019-11-14 | $253.71K derived: sum of 2 quarters · filed 2019-11-14 | $253.71K derived: sum of 3 quarters · filed 2019-11-14 | $253.71K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | $0.00 derived: sum of 2 quarters · filed 2019-09-26 | $0.00 derived: sum of 3 quarters · filed 2019-09-26 | $0.00 10-K · filed 2019-09-26 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-14 | $0.00 derived: sum of 2 quarters · filed 2019-05-14 | $0.00 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $0.00 10-Q · filed 2019-05-14 | $0.00 10-Q · filed 2019-05-14 | ||
| 2017-06-30 | $27.82K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-06 | $63.59K derived: sum of 2 quarters · filed 2018-09-06 | $114.36K derived: sum of 3 quarters · filed 2018-09-06 | $165.13K 10-K · filed 2018-09-06 |
| 2017-03-31 | $35.77K 10-Q · filed 2018-05-14 | $86.54K derived: sum of 2 quarters · filed 2018-05-14 | $137.31K 10-Q · filed 2018-05-14 | $190.34K derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $50.77K 10-Q · filed 2018-02-08 | $101.54K 10-Q · filed 2018-02-08 | $154.57K derived: sum of 3 quarters · filed 2018-02-08 | $234.18K derived: sum of 4 quarters · filed 2018-02-08 |
| 2016-09-30 | $50.77K 10-Q · filed 2017-11-09 | $103.80K derived: sum of 2 quarters · filed 2017-11-09 | $183.41K derived: sum of 3 quarters · filed 2017-11-09 | $269.85K derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $53.02K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $132.64K derived: sum of 2 quarters · filed 2017-08-31 | $219.08K derived: sum of 3 quarters · filed 2017-08-31 | $307.70K 10-K · filed 2017-08-31 |
| 2016-03-31 | $79.61K 10-Q · filed 2017-05-11 | $166.06K derived: sum of 2 quarters · filed 2017-05-11 | $254.68K 10-Q · filed 2017-05-11 | |
| 2015-12-31 | $86.44K 10-Q · filed 2017-02-09 | $175.07K 10-Q · filed 2017-02-09 | ||
| 2015-09-30 | $88.63K 10-Q · filed 2016-11-07 | |||
| 2015-06-30 | $311.00K 10-K · filed 2016-09-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |